↓ Skip to main content

Anti-COVID property of subcutaneous ivermectin in synergy with zinc among midlife moderately symptomatic patients: a structured summary of a study protocol for a randomised controlled trial

Overview of attention for article published in Trials, September 2021
Altmetric Badge

Mentioned by

news
1 news outlet
twitter
20 X users

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
81 Mendeley